IL145957A0 - A pharmaceutical composition comprising an agent which binds with 3-deoxyglucosone - Google Patents

A pharmaceutical composition comprising an agent which binds with 3-deoxyglucosone

Info

Publication number
IL145957A0
IL145957A0 IL14595700A IL14595700A IL145957A0 IL 145957 A0 IL145957 A0 IL 145957A0 IL 14595700 A IL14595700 A IL 14595700A IL 14595700 A IL14595700 A IL 14595700A IL 145957 A0 IL145957 A0 IL 145957A0
Authority
IL
Israel
Prior art keywords
deoxyglucosone
binds
agent
pharmaceutical composition
pharmaceutical
Prior art date
Application number
IL14595700A
Other languages
English (en)
Original Assignee
Fox Chase Cancer Ct
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fox Chase Cancer Ct filed Critical Fox Chase Cancer Ct
Publication of IL145957A0 publication Critical patent/IL145957A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IL14595700A 1999-04-15 2000-04-17 A pharmaceutical composition comprising an agent which binds with 3-deoxyglucosone IL145957A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US12941599P 1999-04-15 1999-04-15
PCT/US2000/010071 WO2000062626A1 (fr) 1999-04-15 2000-04-17 Procede destine a reduire la predisposition a la formation de tumeurs provoquees par la 3-desoxyglucosone et les precurseurs de cette substance

Publications (1)

Publication Number Publication Date
IL145957A0 true IL145957A0 (en) 2002-07-25

Family

ID=22439828

Family Applications (2)

Application Number Title Priority Date Filing Date
IL14595700A IL145957A0 (en) 1999-04-15 2000-04-17 A pharmaceutical composition comprising an agent which binds with 3-deoxyglucosone
IL145957A IL145957A (en) 1999-04-15 2001-10-16 Pharmaceutical composition comprising an agent which binds with 3-deoxyglucosone

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL145957A IL145957A (en) 1999-04-15 2001-10-16 Pharmaceutical composition comprising an agent which binds with 3-deoxyglucosone

Country Status (8)

Country Link
EP (1) EP1175155A4 (fr)
AU (1) AU777745B2 (fr)
CA (1) CA2369755A1 (fr)
HK (1) HK1040164A1 (fr)
IL (2) IL145957A0 (fr)
MX (1) MXPA01010489A (fr)
NZ (1) NZ515049A (fr)
WO (1) WO2000062626A1 (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6518269B1 (en) 2000-07-28 2003-02-11 University Of Arizona Foundation Cancer treatment
US6290929B1 (en) * 2000-07-28 2001-09-18 The Procter & Gamble Company Cancer treatment
SE523153C2 (sv) * 2000-12-28 2004-03-30 Gambro Lundia Ab Metod för detoxifiering av medicinsk lösning
US7622117B2 (en) 2002-04-17 2009-11-24 Dynamis Therapeutics, Inc. 3-deoxyglucosone and skin
US9051583B2 (en) 2011-12-19 2015-06-09 Northwestern University Modified silica shell particles, and methods of making and using the same
AR108671A1 (es) * 2016-06-03 2018-09-12 Enlibrium Inc Análogos de diamida imidodicarbonimidica

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5612332A (en) * 1984-03-19 1997-03-18 Alteon Inc. Di- and triaminoguanidines, and methods of use
US5334617A (en) * 1984-03-19 1994-08-02 The Rockefeller University Amino acids useful as inhibitors of the advanced glycosylation of proteins
US5100919A (en) * 1984-03-19 1992-03-31 The Rockefeller University Biguanides and derivatives thereof as inhibitors of advanced glycosylation of a target protein
US5468777A (en) * 1984-03-19 1995-11-21 The Rockefeller University Method and agents for preventing and reversing the staining of teeth
US5114943A (en) * 1984-03-19 1992-05-19 The Rockefeller University Amino-substituted pyrimidines, derivatives and methods of use therefor
US5258381A (en) * 1984-03-19 1993-11-02 The Rockefeller University 2-substituted-2-imidazolines
US5130324A (en) * 1984-03-19 1992-07-14 The Rockefeller University 2-alkylidene-aminoguanidines and methods of use therefor
US5272165A (en) * 1984-03-19 1993-12-21 The Rockefeller University 2-alkylidene-aminoguanidines and methods of use therefor
US5262152A (en) * 1984-03-19 1993-11-16 The Rockefeller University Amidrazones and derivatives thereof
US5476849A (en) * 1984-03-19 1995-12-19 The Rockefeller University Methods for glycosylation inhibition using amino-benzoic acids and derivatives
US4665192A (en) * 1984-03-19 1987-05-12 The Rockefeller University 2-(2-furoyl)-4(5)-2(furanyl)-1H-imidazole
US5358960A (en) * 1984-03-19 1994-10-25 The Rockefeller University Method for inhibiting advanced glycosylation of proteins using aminosubstituted imidazoles
US5534540A (en) * 1984-03-19 1996-07-09 Alteon Inc. Methods of inhibiting the advanced glycosylation of proteins using tetramic and tetronic acids and compositions therefor
US5221683A (en) * 1984-03-19 1993-06-22 The Rockefeller University Diaminopyridine compounds and methods of use
US5318982A (en) * 1984-03-19 1994-06-07 The Rockefeller University Inhibition of the advanced glycosylation of proteins using substituted-1,2,4-triazoles
US5094694B1 (en) * 1987-03-31 1995-07-11 Dow Chemical Co Process for demineralizing a sugar-containing solution
US5223392A (en) * 1988-01-25 1993-06-29 Exocell, Inc. Monoclonal antibodies against glycated albumin, hybrid cell lines producing these antibodies, and use therefore
WO1994000592A1 (fr) * 1992-06-26 1994-01-06 Exocell, Inc. Anticorps monoclonaux agissant contre des lipoproteines glycatees de faible densite
US5518720A (en) * 1992-12-30 1996-05-21 Exocell, Inc. Treatment of complications of diabetes with substances reactive with the fructosyl-lysine structure in glycated albumin
US5500439A (en) * 1993-12-09 1996-03-19 Alteon Inc. Aminopyrazoles
US5661139A (en) * 1995-01-13 1997-08-26 Alteon Inc. Bis-(2-aryl) hydrazones
US5698563A (en) * 1995-01-13 1997-12-16 Alteon Inc. Bis- hydrazones!
US5656261A (en) * 1995-01-18 1997-08-12 The Picower Institute For Medical Research Preventing and reversing advanced glycosylation endproducts
US5850840A (en) * 1995-11-15 1998-12-22 Alteon Inc. Methods for measurement and treatment predicated on the presence of advanced glycosylation endproducts in tobacco and its combustion byproducts
CN1211321A (zh) * 1995-12-26 1999-03-17 皮考瓦医疗研究院 基于烟草及其燃烧副产物中存在的高级糖基化终产物的测定和处理方法
JPH10182460A (ja) * 1996-12-27 1998-07-07 Nippon Zoki Pharmaceut Co Ltd ３−デオキシグルコソン生成阻害剤
US6004958A (en) * 1997-02-05 1999-12-21 Fox Chase Cancer Center Compounds and methods for therapeutic intervention in preventing diabetic complications and procedures for assessing a diabetic's risk of developing complications and determining the efficacy of therapeutic intervention
CN1331599A (zh) * 1998-10-28 2002-01-16 福克斯契思癌症中心 化合物及其用于治疗糖尿病并发症的用途

Also Published As

Publication number Publication date
AU777745B2 (en) 2004-10-28
IL145957A (en) 2007-02-11
WO2000062626A1 (fr) 2000-10-26
EP1175155A4 (fr) 2005-10-19
HK1040164A1 (zh) 2002-05-31
MXPA01010489A (es) 2002-05-06
CA2369755A1 (fr) 2000-10-26
AU4350100A (en) 2000-11-02
NZ515049A (en) 2004-12-24
EP1175155A1 (fr) 2002-01-30

Similar Documents

Publication Publication Date Title
EG24357A (en) New Pharmaceutical composition
PL351387A1 (en) Pharmaceutical composition
IL152659A0 (en) Pharmaceutical composition
HK1075889A1 (en) Pharmaceutical composition
HUP0204137A3 (en) Pharmaceutical composition comprising fulvestrant
HUP0204555A3 (en) Pharmaceutical composition
IL187526A0 (en) Pharmaceutical compositions containing an a?? fragment
HUP0202513A2 (en) Betha-carboline pharmaceutical compositions
GB0028088D0 (en) Pharmaceutical compositions
GB0001662D0 (en) Pharmaceutical compositions
GB9923436D0 (en) Pharmaceutical compositions
ZA200000857B (en) Pharmaceutical composition.
HUP0000137A3 (en) Controller-release pharmaceutical composition containing anangetics
GB9904163D0 (en) Pharmaceutical compositions
IL154238A0 (en) Pharmaceutical composition
HRP20020345A2 (en) Ciclesonide-containing aqueous pharmaceutical composition
GB9911017D0 (en) Pharmaceutical compositions
IL145957A0 (en) A pharmaceutical composition comprising an agent which binds with 3-deoxyglucosone
GB9904911D0 (en) Pharmaceutical compositions
GB0005382D0 (en) Pharmaceutical composition
GB9902651D0 (en) Pharmaceutical compositions
GB0101094D0 (en) Pharmaceutical composition
GB0002691D0 (en) Pharmaceutical composition
GB9916413D0 (en) Pharmaceutical composition
GB9916210D0 (en) Pharmaceutical composition

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed